Pluristem Therapeutics, Inc. (PSTI) News Headlines

▮ More

Date

Headline

7/13/2022 6:37:09 AM Pluristem's Phase 3 Study Of PLX-PAD To Treat Muscle Injury Does Not Meet Primary Goal

7/13/2022 6:14:46 AM Pluristem's PLX-PAD Phase 3 Study In Muscle Regeneration Following Hip Fracture Surgery Fails To Meet Primary Endpoint

1/18/2022 7:41:11 AM Pre-market Movers: BBI, SXTC, IO, SBEV, SRGA…

1/10/2022 10:31:18 AM Pluristem Climbs On Collaboration With Tnuva Of Israel For Commercialization Of Alternative Meat

12/27/2021 7:40:40 AM Pluristem: Phase II Studies Of ARDS Associated With COVID-19 Fails To Meet Primary Efficacy Endpoint

12/27/2021 7:28:01 AM Pluristem: Phase II Studies Of Acute Respiratory Distress Syndrome With COVID-19 Misses Endpoint

1/12/2021 5:42:57 AM Pre-market Movers In Healthcare Sector: TTOO, TMBR, HAPP, PSTI, GOVX, AVGR...

Older Articles